Prevalence of psychiatric comorbidities in chronic obstructive pulmonary disease patients

Chaudhary, Shyam Chand; Nanda, Satyan; Sawlani, Kamal Kumar; Gupta, Kamlesh Kumar; Himanshu, D; Verma, Ajay Kumar

doi:10.4103/0970-2113.177441

Cited by 22 publications

(15 citation statements)

References 18 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 21 Neuropsychiatric disorders, particularly depression, anxiety, and cognitive dysfunction, are a substantial contributor to COPD-related health. 22 , 23 The incidence of cognitive impairment varies from 10% to 61% in COPD patients, based on the study population and neuropsychological assessment. 23 , 24 In the present study, we found cognitive impairment in 17.6% of the patients with COPD, as assessed using MMSE.…”

Section: Discussionmentioning

confidence: 99%

“…The relationship between cognitive dysfunction and the severity of airway obstruction still remains to be elucidated. 2 , 22 Several studies showed that reduced FEV 1 level was related to poor cognitive functions. 8 , 30 Li et al found that global cognitive function was worse in severe COPD patients, compared to mild to moderate COPD patients.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease

et al. 2017

View full text Add to dashboard Cite

The aim of this study was to evaluate the clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease (COPD). A total of 91 patients with stable moderate to very severe COPD were included in this study. Cognitive functions of the patients were evaluated using the mini-mental state examination (MMSE) tool and clock-drawing test. The Brody’s Instrumental Activities of Daily Living (IADL) Questionnaire; COPD assessment test (CAT); body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE); and Charlson comorbidity index were assessed. The patients were divided into two groups as those who were diagnosed with cognitive impairment (group 1, n = 16) and those with normal cognitive functions (group 2, n = 75). Group 1 had a lower arterial partial pressure of oxygen , shorter 6-min walking distance, and higher arterial partial pressure of carbon dioxide (PaCO2) than group 2 (p = 0.01, p = 0.024, p = 0.018, respectively). In group 1, the IADL score was lower, and CAT and BODE scores were higher than group 2 (p = 0.002, p = 0.037, p = 0.012, respectively). When we considered all the patients, there was an independent correlation between the IADL score and MMSE score (p = 0.03). This study revealed that COPD patients with cognitive impairment may have more hypoxemia and limited activities of daily living.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease

et al. 2017

View full text Add to dashboard Cite

show abstract

“… 8 , 13 , 16 In addition, when patients were asked about their psychiatric symptoms, the majority attributed them to experiencing syncopal attacks rather than the opposite. 7 , 12 Finally, the fact that psychosocial impairment was observed in patients with other chronic diseases such as chronic obstructive lung disease, 21 end-stage renal disease, 22 and heart failure 23 , 24 suggests that syncope may be a trigger for experiencing psychiatric traits.…”

Section: Discussionmentioning

confidence: 99%

Psychiatric traits in patients with vasovagal and unexplained syncope

Alhuzaimi¹,

Aljohar²,

AlHadi³

et al. 2018

IJGM

View full text Add to dashboard Cite

PurposeSyncope is a common condition affecting almost one-third of the general population. The present study measures the prevalence of psychiatric traits in patients presenting with syncope (unexplained and vasovagal) and whether recurrent attacks have an impact on psychiatric profiles.Patients and methodsThis is a case–control study in a tertiary hospital enrolling all patients aged ≥12 years with single or recurrent syncopal attacks. A self-reporting psychometric questionnaire (The Symptoms Checklist-90-Revised) was used to screen for depression, anxiety, somatization disorder, and phobia. Crude comparisons of average scores were done. Further, multiple logistic regression analyses were carried out to measure the impact of syncope on each psychiatric domain. The control group were matched for age, gender, and chronic illnesses with a ratio of 1:3.ResultsThere were 43 cases and 129 control subjects, with predominance of females (67.4%) and an average age of 33.8 years (standard deviation = 16). There were no significant differences in average scores of depression (13 vs 14.53, P = 0.31), anxiety (11.3 vs 10.4, P = 0.51), or phobia (5.4 vs 5.2, P = 0.88). However, the syncope group had a higher average score for somatization disorder (18.53 vs 13.66, P = 0.002). Binary logistic regression model showed that the association between syncope and somatization disorder was independent of competing confounders (odds ratio = 3.75, 95% confidence interval: 1.72, 8.15, P = 0.001). A sub-analysis of the case group showed that patients with multiple syncopal attacks (six or more) had higher average scores of depression, anxiety, phobia, and somatization disorder compared to those who had less than six attacks.ConclusionSyncope was independently associated with somatization disorder traits. Further, recurrent syncope resulted in greater deterioration of patients’ psychiatric profiles. Thus, taking into account the psychiatric status in the management of such patients is crucial.

show abstract

“…P sychiatric co-morbidities, chiefl y, anxiety and depression are common among the patients with chronic obstructive pulmonary disease (COPD) which increase the duration of symptoms as well as the disease course 1 . Experience of severe shortness of breath is likely to contribute anxiety whereas loss and grief related with the disability due to COPD may lead to depression 2 .…”

Section: Introductionmentioning

confidence: 99%

Anxiety and Depression Among Chronic Obstructive Pulmonary Disease Patients in A Tertiary Care Hospital, Nepal

Roka

Aryal

Ghimire

et al. 2018

J. Kathmandu Med. Coll.

View full text Add to dashboard Cite

Background: Psychiatric co-morbidities such as anxiety and depression among patients with chronic obstructive pulmonary disease exacerbate the disease, prolong the hospital stay, increase the disease symptoms and deter the quality of life. Objective: To assess the proportion of anxiety or depression among patients with chronic obstructive pulmonary disease in a tertiary care hospital. Methodology: We carried out a cross sectional study interviewing 307 patients from a tertiary care hospital using sequential sampling technique. We used structured questionnaire and included hospital anxiety and depression scale to measure anxiety and depression. We considered a summed score of 11 on each of the subscale as a case-ness of anxiety and/or depression. We present the results as proportion and adjusted odds ratio with 95% confi dence interval. Results: We found 31% of the patients as having anxiety and 35% having depression, with 19% of co-morbidity. We found higher odds of anxiety among certain groups: female (adjusted odds ratio -1.93, 95%CI: 1.10-3.39), participants visiting doctor or health facility to manage their fi rst episode of illness (adjusted odds ratio -2.56, 95%CI: 1.35-4.87). Also, the latter group had higher odds (adjusted odds ratio -3.57, 95%CI: 1.54-8.29) of co-morbid anxiety and depression. Conclusion: We found a substantial proportion of participants with case-ness of anxiety and depression. Psy chiatric evaluation and additional management of these associated comorbidities could make the management of chronic obstructive pulmonary disease comprehensive and would improve quality of life of such patients.

show abstract

Prevalence of psychiatric comorbidities in chronic obstructive pulmonary disease patients

Cited by 22 publications

References 18 publications

Clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease

Clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease

Psychiatric traits in patients with vasovagal and unexplained syncope

Anxiety and Depression Among Chronic Obstructive Pulmonary Disease Patients in A Tertiary Care Hospital, Nepal

Contact Info

Product

Resources

About